M.E. Allison & Co
PFE icon

M.E. Allison & Co’s Pfizer PFE Stock Holding History

M.E. Allison & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.19M Buy
41,878
+136
+0.3% +$3.62K 0.67% 39
2026
Q2 		$1.01M Buy
41,742
+2,112
+5% +$55.2K 0.58% 45
2026
Q1 		$1.11M Buy
39,630
+1,956
+5% +$52.1K 0.74% 36
2025
Q4 		$938K Buy
37,674
+1,162
+3% +$29.3K 0.64% 44
2025
Q3 		$930K Buy
36,512
+164
+0.5% +$4.05K 0.65% 43
2025
Q2 		$881K Buy
36,348
+11,186
+44% +$261K 0.71% 39
2025
Q1 		$638K Buy
25,162
+8,851
+54% +$232K 0.63% 44
2024
Q4 		$247K Buy
+16,311
New +$442K 0.27% 114

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Willis Investment Counsel
Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

M.E. Allison & Co's PFE Position: Q3 2026 in Review

M.E. Allison & Co increased its Pfizer (PFE) stake by 0.33% in Q3 2026, buying an estimated $3.62K and bringing the position to 41,878 shares worth $1.19M. The position accounts for 0.67% of the portfolio, ranked #39.

M.E. Allison & Co first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. 661 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • M.E. Allison & Co held 41,878 shares of Pfizer worth $1.19M as of Q3 2026.
  • M.E. Allison & Co bought 136 Pfizer shares in Q3 2026, an estimated $3.62K.
  • Pfizer made up 0.67% of M.E. Allison & Co's portfolio in Q3 2026, its #39 holding.
  • M.E. Allison & Co first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
  • 661 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on M.E. Allison & Co's 13F filing for Q3 2026, filed 9 Oct 2026.